Asymchem Laboratories Tianjin : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
April 20, 2022 at 08:05 am
Share
[title]
[date]
[link]
[market]
[doc type]
[stock code]
[stock name]
ISSUE OF THE THIRD TRANCHE OF SUPER SHORT-TERM FINANCING DEBENTURES FOR THE YEAR 2022
20/04/2022 20:01
Link
SEHK
pdf
01816
CGN POWER
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
20/04/2022 20:01
Link
SEHK
htm
06821
ASYMCHEM
RECORD DATE FOR ANNUAL GENERAL MEETING OF SHAREHOLDER
20/04/2022 20:01
Link
SEHK
pdf
09898
WB-SW
POSTPONEMENT OF BOARD MEETING AND DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE EIGHT MONTHS ENDED 31 AUGUST 2021
20/04/2022 20:00
Link
SEHK
pdf
01565
VIRSCEND EDU
PROPOSED ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION
20/04/2022 19:59
Link
SEHK
pdf
00713
WORLD HOUSEWARE
TRADING HALT
20/04/2022 19:59
Link
SEHK
pdf
01575
MORRIS HOME
NOTICE OF ANNUAL GENERAL MEETING
20/04/2022 19:56
Link
SEHK
pdf
01193
CHINA RES GAS
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
20/04/2022 19:56
Link
SEHK
htm
06821
ASYMCHEM
DELAY IN DESPATCH OF CIRCULAR - MAJOR TRANSACTION AND CONNECTED TRANSACTION DISPOSAL OF BEIJING SHUIMU HUAXIA EDUCATION & TECHNOLOGY CO., LTD.
20/04/2022 19:53
Link
SEHK
pdf
01981
CATHAY EDU
NOTIFICATION LETTER
20/04/2022 19:50
Link
SEHK
pdf
01193
CHINA RES GAS
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR PHASE 2 CLINICAL TRIAL OF HANSIZHUANG (SERPLULIMAB INJECTION) IN COMBINATION WITH HLX07 (A RECOMBINANT HUMANISED ANTI-EGFR MONOCLONAL ANTIBODY INJECTION) AND HANBEITAI (BEVACIZUMAB INJECTION) FOR THE FIRST-LINE TREATMENT OF UNRESECTABLE OR METASTATIC HEPATOCELLULAR CARCINOMA (HCC) WAS APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
20/04/2022 19:49
Link
SEHK
pdf
02696
HENLIUS
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
20/04/2022 19:49
Link
SEHK
htm
06821
ASYMCHEM
PAST CONNECTED TRANSACTION - ENTERING INTO COAL SALES AGREEMENT WITH RISUN SUPPLY MANAGEMENT CO., LTD
20/04/2022 19:48
Link
SEHK
pdf
00975
MONGOL MINING
FORM OF PROXY FOR ANNUAL GENERAL MEETING (AND AT ANY ADJOURNMENT THEREOF) TO BE HELD ON 27 MAY 2022
20/04/2022 19:46
Link
SEHK
pdf
06119
TIAN YUAN GP
NOTICE OF ANNUAL GENERAL MEETING
20/04/2022 19:46
Link
SEHK
pdf
06119
TIAN YUAN GP
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
20/04/2022 19:46
Link
SEHK
htm
00826
TIANGONG INT'L
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
20/04/2022 19:45
Link
SEHK
htm
06821
ASYMCHEM
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
20/04/2022 19:44
Link
SEHK
htm
00826
TIANGONG INT'L
(1) PROPOSED PAYMENT OF FINAL DIVIDEND; (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES; (3) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; AND (4) NOTICE OF ANNUAL GENERAL MEETING
20/04/2022 19:43
Link
SEHK
pdf
06119
TIAN YUAN GP
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
20/04/2022 19:42
Link
SEHK
htm
00826
TIANGONG INT'L
Attachments
Original Link
Original Document
Permalink
Disclaimer
Asymchem Laboratories Tianjin Co. Ltd. published this content on 20 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2022 12:04:03 UTC.
Asymchem Laboratories (Tian Jin) Co Ltd is a China-based company mainly engaged in the contract development manufacturing organization (CDMO) of drugs. The Company's main businesses are the process development, amplification and commercialization of chemical drugs. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company is also engaged in the provision of pharmaceutical formulation solutions, biosynthetic solutions and clinical solutions.
Asymchem Laboratories Tianjin : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section